EGRX/TEVA submit NDA for rapid-infusion formulation of Trenda: http://www.sec.gov/Archives/edgar/data/827871/000082787115000025/tevaeaglebendaacceptedforf.htm Please see #msg-110943484 for the terms of the settlement with respect to this product.